Subscribe free

HPB & Spleen ·

Tumor Burden Score as a Prognostic Factor

Researchers found that Tumor Burden Score (TBS) significantly influences survival in hepatocellular carcinoma (HCC) patients post-resection. A retrospective analysis of 291 patients showed median overall survival (OS) of 107.4 months for BCLC stage A and 42.7 months for stage B with low TBS. High TBS patients had median OS of 42.3, 25.72, and 16.9 months for stages A, B, and C, respectively. TBS helps stratify BCLC B and C patients, identifying those who benefit from resection for long-term survival.

Journal Article by Nandy K, Patkar S (…) Goel M et 3 al. in HPB (Oxford)

Copyright © 2024 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

read the whole article in HPB (Oxford)

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

Br J Surg5 Nov 2026

Rectal cancer and liver spread: similar outcomes

Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.

All papers in HPB & Spleen →